SYP-1512

SYP-1512 · Samyang Biopharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYP-1512, covering 2017-07-06 to 2017-07-06. Get the full timeline:

Most recent: Clinical Trial Update: Crossover Study to Compare Pharmacokinetic Property of SYP-1512 Tab and Revlimid Cap in Healthy Male Volunteers [Phase 1]

See pricing